Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization,  natural biodistribution, and acute toxicity
Michael M Galagudza1, Dmitry V Korolev1, Dmitry L Sonin1, Viktor N Postnov2, Garry V Papayan3, Ivan S Uskov1, Anastasia V Belozertseva1, Eugene V Shlyakhto11Institute of Experimental Medicine, VA. Almazov Federal Heart, Blood and Endocrinology Center, St-Petersburg, Russian Federation; 2Chemical Fac...
Main Authors: | Michael M Galagudza, Dmitry V Korolev, Dmitry L Sonin, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2010-03-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/targeted-drug-delivery-into-reversibly-injured-myocardium-with-silica--a4136 |
Similar Items
-
In Vivo Toxicity of Intravenously Administered Silica and Silicon Nanoparticles
by: Michael Galagudza, et al.
Published: (2012-10-01) -
Biological Safety and Biodistribution of Chitosan Nanoparticles
by: Dmitry Sonin, et al.
Published: (2020-04-01) -
Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles
by: Galagudza M, et al.
Published: (2012-04-01) -
The Bioavailability, Biodistribution, and Toxic Effects of Silica-Coated Upconversion Nanoparticles in vivo
by: Mingzhu Zhou, et al.
Published: (2019-04-01) -
Targeted delivery of thymosin beta 4 to the injured myocardium using CREKA-conjugated nanoparticles
by: Huang Z, et al.
Published: (2017-04-01)